Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,867.00
+30.70 (1.67%)
Feb 18, 2026, 12:00 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 302.54 billion as of February 17, 2026. Its market cap has increased by 21.87% in one year.
Market Cap
302.54B
Enterprise Value
273.55B
Revenue
61.13B
Ranking
n/a
PE Ratio
35.71
Stock Price
1,867.00
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 302.54B, an increase of 1.83%. That is a compound annual growth rate of 0.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 302.54B | 6.64% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 652.41B |
| Glenmark Pharmaceuticals | 575.35B |
| Laurus Labs | 547.09B |
| Ipca Laboratories | 378.43B |
| Ajanta Pharma | 369.39B |
| Emcure Pharmaceuticals | 278.80B |
| Wockhardt | 226.87B |
| Piramal Pharma | 218.64B |